Patterns-of-failure after helical tomotherapy-based chemoradiotherapy for head and neck cancer: Implications for CTV margin, elective nodal dose and bilateral parotid sparing-Reference-Cited by-同舟云学术

Patterns-of-failure after helical tomotherapy-based chemoradiotherapy for head and neck cancer: Implications for CTV margin, elective nodal dose and bilateral parotid sparing

Published:2014-05 Issue:5 Volume:50 Page:520-526
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Dandekar Virag,Morgan Tiffany,Turian Julius,Fidler Mary Jo,Showel John,Nielsen Thomas,Coleman Joy,Diaz Aidnag,Sher David J.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference32 articles.

1. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unrespectable squamous cell head and neck cancer;Adelstein;J Clin Oncol,2003

2. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer;Brizel;N Engl J Med,1998

3. Final results of the 94-01 French head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma;Denis;J Clin Oncol,2004

4. MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009

5. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis;Machtay;J Clin Oncol,2008

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose and volume de-escalation of radiotherapy in head and neck cancer;Critical Reviews in Oncology/Hematology;2023-06

2. Why subclinical involvement is prescribed the same high dose as gross tumor volume: A study on high‐dose clinical target volume in intensity‐modulated radiotherapy plan of nasopharyngeal carcinoma;Head & Neck;2023-03

3. Gross tumor volume margin and local control in p16‐positive oropharynx cancer patients treated with intensity modulated proton therapy;Head & Neck;2023-02-25

4. PET/CT;PET Clinics;2022-04

5. Recurrence Patterns After IMRT/VMAT in Head and Neck Cancer;Frontiers in Oncology;2021-09-16